UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1.
Full Text
Signaling by the tumor necrosis factor receptor superfamily in B‐cell biology and disease
Immunological reviews, ISSN 0105-2896, 11/2011, Volume 244, Issue 1, pp. 115 - 133
BAFF | B cell | CD40 | BCMA | NF‐κB | TACI | NF-κB | Life Sciences & Biomedicine | Immunology | Science & Technology | Cell Proliferation | Humans | NF-kappa B - immunology | NF-kappa B - metabolism | Transmembrane Activator and CAML Interactor Protein - metabolism | Signal Transduction - immunology | CD40 Antigens - metabolism | B-Cell Activating Factor - immunology | B-Lymphocyte Subsets - immunology | CD40 Antigens - genetics | B-Cell Activation Factor Receptor - genetics | B-Lymphocytes - metabolism | B-Cell Activation Factor Receptor - immunology | B-Cell Maturation Antigen - immunology | Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology | Gene Expression | Mice, Transgenic | Cell Survival - immunology | Immunity, Innate | Tumor Necrosis Factor Ligand Superfamily Member 13 - metabolism | Transmembrane Activator and CAML Interactor Protein - genetics | B-Cell Activation Factor Receptor - metabolism | Animals | B-Cell Activating Factor - metabolism | B-Cell Maturation Antigen - metabolism | B-Lymphocytes - immunology | B-Lymphocyte Subsets - metabolism | NF-kappa B - genetics | B-Cell Activating Factor - genetics | Neoplasms - immunology | Autoimmune Diseases | Tumor Necrosis Factor Ligand Superfamily Member 13 - genetics | Mice | B-Cell Maturation Antigen - genetics | Transmembrane Activator and CAML Interactor Protein - immunology | CD40 Antigens - immunology | Autoimmunity | Antigens | Tumor necrosis factor | Tumors | Necrosis | Index Medicus
Journal Article
Seminars in immunology, ISSN 1044-5323, 2006, Volume 18, Issue 5, pp. 263 - 275
Signaling | BAFF | B cells | Structure | Splice variants | Life Sciences & Biomedicine | Immunology | Science & Technology | B-Cell Activating Factor - physiology | Alternative Splicing | Humans | Substrate Specificity | Structure-Activity Relationship | Lymphocyte Subsets - immunology | Immunoglobulin Class Switching - physiology | Protein Kinase C-delta - antagonists & inhibitors | B-Cell Activating Factor - immunology | Tumor Necrosis Factor Ligand Superfamily Member 13 - chemistry | B-Cell Activation Factor Receptor - genetics | B-Cell Activation Factor Receptor - immunology | B-Cell Activation Factor Receptor - chemistry | Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology | B-Lymphocytes - cytology | Transmembrane Activator and CAML Interactor Protein - chemistry | Signal Transduction | B-Cell Maturation Antigen - physiology | Lymphocyte Activation | B-Cell Activating Factor - chemistry | Tumor Necrosis Factor Ligand Superfamily Member 13 - physiology | Models, Molecular | B-Cell Activation Factor Receptor - physiology | Transmembrane Activator and CAML Interactor Protein - physiology | Protein Interaction Mapping | Transmembrane Activator and CAML Interactor Protein - genetics | Animals | B-Lymphocytes - immunology | B-Cell Activating Factor - genetics | NF-kappa B - physiology | Protein Conformation | Tumor Necrosis Factor Ligand Superfamily Member 13 - genetics | Mice | NF-kappa B p50 Subunit - physiology | Apoptosis - physiology | Transmembrane Activator and CAML Interactor Protein - immunology | Antigen Presentation - physiology | Index Medicus
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 03/2017, Volume 77, Issue 5, pp. 1097 - 1107
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology | Lymphoma, Large B-Cell, Diffuse - pathology | Interleukin-8 - biosynthesis | Humans | Neutrophils - immunology | Lymphoma, Large B-Cell, Diffuse - metabolism | Tumor Microenvironment - immunology | Animals | Tumor Necrosis Factor Ligand Superfamily Member 13 - biosynthesis | Lymphoma, Large B-Cell, Diffuse - immunology | Ligands | Tumor Necrosis Factor Ligand Superfamily Member 13 - genetics | Mice | Interleukin-8 - immunology | Lymphoma, Large B-Cell, Diffuse - genetics | Neutrophils - metabolism | Neutrophils - pathology | Tumor cells | Neutrophils | Leukocytes (neutrophilic) | Lymphoma | Blood | APRIL protein | Recruitment | Lymphocytes B | Tumor necrosis factor | DNA methylation | Acetylation | Chemokines | Interleukin 8 | Deoxyribonucleic acid--DNA | Tumors | Cancer | B-cell lymphoma | Index Medicus
Journal Article
4.
Full Text
Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
Nature reviews. Rheumatology, ISSN 1759-4790, 04/2017, Volume 13, Issue 4, pp. 217 - 233
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Fas Ligand Protein - metabolism | Rheumatic Diseases - drug therapy | OX40 Ligand - metabolism | CD27 Ligand - antagonists & inhibitors | Dendritic Cells - immunology | Humans | Lymphotoxin-alpha - metabolism | Molecular Targeted Therapy | 4-1BB Ligand - antagonists & inhibitors | TNF-Related Apoptosis-Inducing Ligand - antagonists & inhibitors | CD40 Ligand - metabolism | CD27 Ligand - metabolism | Cell Death | Rheumatic Diseases - immunology | Signal Transduction | Lymphocyte Activation | Tumor Necrosis Factors - metabolism | 4-1BB Ligand - metabolism | Immune Tolerance | Tumor Necrosis Factor Ligand Superfamily Member 15 - metabolism | TNF-Related Apoptosis-Inducing Ligand - metabolism | Tumor Necrosis Factor Ligand Superfamily Member 14 - metabolism | Tumor Necrosis Factors - immunology | OX40 Ligand - antagonists & inhibitors | Cytokine TWEAK | Fas Ligand Protein - antagonists & inhibitors | Animals | Tumor Necrosis Factor Ligand Superfamily Member 15 - antagonists & inhibitors | T-Lymphocytes - immunology | Tumor Necrosis Factor Ligand Superfamily Member 14 - antagonists & inhibitors | CD40 Ligand - antagonists & inhibitors | Lymphotoxin-alpha - antagonists & inhibitors | Tumor Necrosis Factors - antagonists & inhibitors | Care and treatment | Cytokines | Tumor necrosis factor | Rheumatic diseases | Development and progression | Genetic aspects | Health aspects | Index Medicus
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 08/2008, Volume 118, Issue 8, pp. 2887 - 2895
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Cell Line | Mucous Membrane - immunology | Heparan Sulfate Proteoglycans - metabolism | Humans | Tumor Necrosis Factor Ligand Superfamily Member 13 - secretion | Tumor Necrosis Factor Ligand Superfamily Member 13 - genetics | Kidney - cytology | Neutrophils - metabolism | Plasma Cells - immunology | Cell proliferation | Polymerase chain reaction | Control | Usage | Neutrophils | Physiological aspects | Research | Index Medicus | Abridged Index Medicus
Journal Article